The Role of Mitomycin C in the Treatment of Ocular Surface Squamous Neoplasia
Journal of Ophthalmic and Optometric Sciences · 02.04.2023
DOI: 10.22037/joos.v7i2.45981 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Ophthalmic and Optometric Sciences, erschienen am 02.04.2023. Verfasst von Nader Nassiri und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Ocular surface tumors, arising from the squamous epithelium, melanocytes, and lymphocytic resident cells of the conjunctival stroma and cornea, present a challenge in ophthalmic oncology. Ocular surface squamous neoplasia (OSSN) encompasses a spectrum of epithelial squamous malignancies that range from mild to severe dysplasia to invasive squamous cell carcinoma. Traditionally, surgical excision has been the treatment of choice for OSSN, but Mitomycin C (MMC) has emerged as a valuable adjunctive treatment option, decreasing the recurrence rate of these tumors. This review provides an overview of the use of MMC in the management of OSSN, including dosing regimens, complications, and long-term outcomes.
Schlagwörter
Zitieren
APA
Nassiri, N., Shahriari, M., Rezaeyeh, A. P., Kavousnezhad, S., & Yadgari, M. (2023). The Role of Mitomycin C in the Treatment of Ocular Surface Squamous Neoplasia. Journal of Ophthalmic and Optometric Sciences. https://doi.org/10.22037/joos.v7i2.45981
Vancouver
Nassiri N, Shahriari M, Rezaeyeh AP, Kavousnezhad S, Yadgari M. The Role of Mitomycin C in the Treatment of Ocular Surface Squamous Neoplasia. Journal of Ophthalmic and Optometric Sciences. 2023. doi:10.22037/joos.v7i2.45981
BibTeX
@article{Nassiri2023,
author = {Nassiri, Nader and Shahriari, Mansoor and Rezaeyeh, Arvin Porkar and Kavousnezhad, Sara and Yadgari, Maryam},
title = {The Role of Mitomycin C in the Treatment of Ocular Surface Squamous Neoplasia},
journal = {Journal of Ophthalmic and Optometric Sciences},
year = {2023},
doi = {10.22037/joos.v7i2.45981}
}
EUVIMED